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Flaviviruses have evolved complex mechanisms to evade the mammalian host immune
systems including the RIG-I (retinoic acid-inducible gene I) like receptor (RLR) signaling.
Zika virus (ZIKV) is a re-emerging flavivirus that is associated with severe neonatal
microcephaly and adult Guillain-Barre syndrome. However, the molecular mechanisms
underlying ZIKV pathogenesis remain poorly defined. Here we report that ZIKV nonstructural protein 4A (NS4A) impairs the RLR-mitochondrial antiviral-signaling protein
(MAVS) interaction and subsequent induction of antiviral immune responses. In human
trophoblasts, both RIG-I and melanoma differentiation-associated protein 5 (MDA5)
contribute to type I interferon (IFN) induction and control ZIKV replication. Type I IFN
induction by ZIKV is almost completely abolished in MAVS−/− cells. NS4A represses
RLR-, but not Toll-like receptor-mediated immune responses. NS4A specifically binds
the N-terminal caspase activation and recruitment domain (CARD) of MAVS and thus
blocks its accessibility by RLRs. Our study provides in-depth understanding of the
molecular mechanisms of immune evasion by ZIKV and its pathogenesis.
Keywords: flavivirus, Zika, non-structural protein 4A, NS4A, RIG-I like receptors, RLR
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INTRODUCTION
Zika virus (ZIKV) is a re-emerging Flaviviridae member that was first identified in a sentinel rhesus
monkey in the Zika Forest of Uganda in 1947 (Dick et al., 1952). ZIKV then spread to Asia and
more recently the Central and South America (Cao-Lormeau and Musso, 2014; Colon-Gonzalez
et al., 2017; Fu et al., 2017; Perry et al., 2017). Increasing evidence suggests that ZIKV infection is
responsible for severe neurological complications such as neonatal microcephaly, adult GuillainBarre syndrome, and maculopathy (Oehler et al., 2014; Cao-Lormeau et al., 2016; Miranda-Filho
Dde et al., 2016; Petersen et al., 2016). Although intensive efforts are being invested, unfortunately
no vaccines or therapeutics are available to prevent and treat ZIKV infection to date (Fauci and
Morens, 2016).
Type I interferons (IFNs) are a critical host defense system against ZIKV infection and are
initiated primarily by retinoic acid-inducible gene I (RIG-I)-like receptors (RLRs), which sense
cytoplasmic dsRNA (Loo and Gale, 2011). The RLR family has 3 members, RIG-I, melanoma
differentiation-associated gene 5 (MDA5), and Laboratory of Genetics and Physiology 2 (LGP2).
The function of MDA5 and RIG-I in RNA virus infection has been well established. Once bound
by viral RNA, RIG-I/MDA5 will undergo conformational change and expose its N-terminal
caspase-recruitment domains (CARD) which bind the CARD of mitochondrial antiviral-signaling
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(Cat# E1910) was available from Promega (Madison, WI,
United States). Human embryonic kidney (HEK) 293 T (Cat#
CRL-3216), Vero cells (monkey kidney epithelial cells, Cat# CCL81), placental trophoblast (Cat# CRL-3271) cell lines, and the
Zika virus FLR strain (Cat# VR-1844) were from American Type
Tissue Culture (Manassas, VA, United States). The Zika virus
FS13025 (Cambodia, 2010) was a kind gift of Dr. Tian Wang
at the University of Texas Medical Branch at Galveston, TX,
United States. Green fluorescence protein (GFP) tagged vesicular
stomatitis virus (VSV) was derived from the Indiana strain of
VSV (You et al., 2013).

protein (MAVS). MAVS subsequently recruits TRAF3 and
TRAF6 to its C-terminus and activates downstream signaling
proteins such as TBK1, NF-κB, IRF3, and IRF7, up-regulating
expression of type I interferon (IFN) as well as inflammatory
cytokines and chemokines (Seth et al., 2006; Sun et al., 2010).
The flaviviral genome is a single stranded, positivesense RNA encoding an envelope protein (E) and a
pre-membrane/membrane (PrM/M) that make up the viral
envelope together with a lipid bilayer as well as seven nonstructural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, and
NS5) that are required for viral replication and are involved
in immune evasion (Ngono and Shresta, 2018). The ability of
many medically important flaviviruses to interfere with the RLR
signaling and type I IFN response has been well documented
(Chen et al., 2017). For instance, the NS2 of dengue virus
(DENV) and hepatitis C (HCV) inhibits type I IFN induction
by blocking TBK1/IRF3 phosphorylation (Kaukinen et al., 2013;
Dalrymple et al., 2015). The NS3 of HCV is a dominant negative
interactor of TBK1 and thus blocks IRF3 activation (Otsuka
et al., 2005); it also cleaves MAVS and inhibits RLR-mediated
immune responses together with NS2B (Li et al., 2005; Meylan
et al., 2005). The NS2A of Kunjin virus (KUNV) inhibits the
IFN-induced gene expression (Liu et al., 2004). The NS4A
and NS4B of several flaviviruses inhibit JAK-STAT and RLR
signaling through multiple mechanisms (Munoz-Jordan et al.,
2003; Ding et al., 2013; Nitta et al., 2013; Yi et al., 2015). The
NS5 of several flaviviruses including ZIKV are able to interfere
with the JAK-STAT signaling and induction of antiviral effectors
(Best et al., 2005; Lin et al., 2006; Werme et al., 2008; Ashour
et al., 2010; Laurent-Rolle et al., 2010, 2014; Kumthip et al., 2012;
Grant et al., 2016). However, to date, there is little information
about the molecular mechanisms of immune evasion by ZIKV.
We hereby report that ZIKV interferes with the RLR signaling
to dampen type I IFN response and enhance its pathogenesis.
Our results identify ZIKV NS4A in particular as a suppressor
of the RLR pathway by interrupting RLR-MAVS interaction,
preventing induction of type I IFNs and inflammatory responses
that contain ZIKV replication.

Plasmid Construction
The DNA encoding the amino residues 1–100, 1–300 together
with OMP25 residues 109–145 was cloned into pcDNA3.1-ZeoN-FLAG vector for expression of mitochondrial FLAG-MAVS1–
100, 1–300. The FLAG tagged full-length human MAVS, MAVS
1101–452, MDA5, RIG-I, 1RIG-I, GFP-IRF3-5D, and GFPTBK1 have been described in our previous study (Wang et al.,
2013).
The ZIKV FS13025 (Cambodia, 2010, GenBank Accession:
JN860885.1) genes (capsid, membrane, envelope, NS1, NS2A,
NS2B, NS3, NS4A, and NS4B) were amplified by PCR and
inserted into a pcDNA3.1-FLAG or pcDNA3.1-Myc (N-terminal)
expression vector. The primers are listed in Table 1.

Cell Culture and Transfection
2fGTH and Vero/HEK293T cells and trophoblasts were grown
in DMEM/RPMI1640, respectively (Life Technologies, Grand
Island, NY, United States) supplemented with 10% FBS and 1×
antibiotics/antimycotics in a 37◦ C incubator filled with 5% CO2 .
Viruses were amplified in Vero cells and the viral titer was
determined by plaque forming assays as previously described

TABLE 1 | The ZIKV FS13025 (Cambodia, 2010, GenBank Accession:
JN860885.1) gene primers.

MATERIALS AND METHODS

Primers

Capsid

Forward: GCGGCCGCGAAAAACCCAAAGAAGAAATCCGGA

Membrane

Forward: GCGGCCGCGGTGGAGGTCACTAGACGT

Envelope

Forward: GCGGCCGCGATCAGGTGCATAGGAGTCAG

NS1

Forward: GCGGCCGCGGCCGTCTCTGCTGATGTGG

NS2A

Forward: GCGGCCGCGACTGCAGGATCAACTGATCA

NS2B

Forward: GCGGCCGCGAGTGGGAAGCGGAGCTGGC

NS3

Forward: GCGGCCGCGACTGGAAAAAGGAGTGGT

NS4A

Forward: GCGGCCGCG GCTGGGAAAAGAGGAGCG

NS4B

Forward: GCGGCCGCGCTGGGCTTGATTACCGCCA

Reverse: GGATCCCTATGCCATGGCTGTGGTCAGCA

Reagents and Cell Lines

Reverse: GGATCCCTAGCTGTATGCCGGGGCAATCA

The rabbit anti-MDA5 (Cat# 5321), RIG-I (Cat# 3743), Myctag (Cat# 2278), and Actin (Cat# 8456) were purchased from
Cell Signaling Technology (Danvers, MA, United States). M2
(anti-FLAG) magnetic beads (Cat# A2220), anti-FLAG antibody
(Cat# F3165), and 3× FLAG peptide (Cat# F4799) were available
at Sigma-Aldrich (St. Louis, MO, United States). Mouse antihuman MAVS (Cat# SC-365333) was a product of Santa Cruz
Biotechnology (Santa Cruz, CA, United States). Lipofectamine
2000 (Cat# 11668019) was obtained from Thermo Fisher
Scientific. The heavy molecule weight polyinosinic-polycytidylic
acid (poly I:C-H), light molecular weight (polyI:C-L), and
HEK293 cell line stably expressing human TLR4-MD2-CD14
(Cat# 293-htlr4md2cd14) were purchased from InvivoGen (San
Diego, CA, United States). The Dual-Luciferase Reporter Assay

Frontiers in Microbiology | www.frontiersin.org

ZIKV gene

Reverse: GAATTCCTATGTGGATAAGAAGATCAA
Reverse: GGATCCCTACACCATTGACCTTACTAAG
Reverse: GGATCCCTA CCTTGTGAGCAACAGCAGT
Reverse: GGATCCCTACTTCACATACACGTACCA
Reverse: GAATTCCTAGGCAAACTCTTTGAATGAC
Reverse: GGA TCCCTA AAGACCCACTGCTACCAT
Reverse: GGATCCCTA CAAGCCAGCGTTTCTTGTT
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(Wang et al., 2008). Briefly, 100 µl of viral samples diluted with
sterile PBS by 101 –105 time were applied to confluent Vero cell
monolayer. Plaques were visualized using Neutral red (SigmaAldrich) after 1–3 days of incubation at 37◦ C 5% CO2 .

Biochemical Assays
For immunoblotting, cells were lysed in lysis buffer [50 mM
Tris–HCl (pH 7.5), 150 mM NaCl, 5 mM EDTA, 1% Triton
X-100] supplemented with Complete Protease Inhibitor Cocktail
(Roche Diagnostics, Indianapolis, IN, United States). Cell
lysates were resolved on a 10 or 15% SDS-PAGE gel, and
the separated proteins were transferred to a nitrocellulose
membrane. The proteins of interest on the membrane
were probed with specific primary antibodies, followed by
HRP-conjugated secondary antisera, and detected with an
enhanced chemiluminescence system from GE Healthcare (Port
Washington, NY, United States).
FLAG-immunoprecipitation was performed essentially
according to the manufacturer’s manual (Sigma-Aldrich,
St. Louis, MO, United States). Briefly, HEK293T cells were
transfected with expression plasmids using Lipofectamine
2000. At 24 h post-transfection, the cells were lyzed in lysis
buffer (50 mM Tris-HCl, pH 7.4, 0.5% NP-40, 2 mM EDTA,
and 150 mM NaCl, with complete protease inhibitors).
The lysates were cleared by centrifugation at high speed
and then incubated for 2 h with M2 magnetic beads with
gentle agitation at 4◦ C. After 4 washes with ice-cold lysis
buffer and 2 washes with 1× Tris buffered saline (TBS),
the proteins bound to M2 beads were eluted using 3×
FLAG peptides, resolved by SDS-PAGE and detected by
immunoblotting.

In-well Transfection
Transfection of plasmid DNA or polyI:C into HEK293T cells
with Lipofectamine 2000 (Thermo Fisher Cat# 11668019)
was performed following exactly the product manual. Briefly,
HEK293T cells were grown in a 24-well culture plate to ∼70–80%
confluence on the day of transfection. The plasmid DNA/polyI:C
was suspended in 50 µl of serum-free culture medium, and 2 µl
of Lipofectamine 2000 in 50 µl of serum-free culture medium.
The diluted DNA and Lipofectamine were incubated separately
at room temperature for 5 min, and then mixed together.
After 15 min incubation, the mix was added to each culture
well dropwise with gentle shaking. The transfected cells were
incubated at 37◦ C, 5% CO2 for 24 h or desirable time specified
in each figure legend.

In-suspension Transfection
For hard-to-transfect adherent cells such as trophoblasts,
transfection was carried out in cell suspension. Briefly, cells were
dislodged by trypsin digestion and 2 × 105 cells were pelleted
by brief centrifugation. The cell pellet was then suspended in
the transfection mix (DNA + Lipofectamine 2000 prepared as
above) for 20 min with intermittent gentle agitation. 0.5 ml of
pre-warmed RPMI1640 complete medium was then added and
plated into one well of a 24-well plate for further culture.

Immunofluorescent Microscopy
Trophoblasts were transfected with empty vector or pcDNA3.1FLAG-NS4A at a DNA/cell ratio of 1 µg/million cells as described
in the In-suspension transfection section above. The cells were
then seeded into an 8-chamber culture slide at a density of
2 × 104 cells per well and incubated overnight at 37◦ C in 5%
CO2 . The cells were then transfected with 10 µg/ml polyI:C-H
as described in the In-well transfection section above. Eight hours
after polyI:C-H treatment, trophoblasts were then washed with
ice-cold 1× PBS once, fixed with 4% paraformaldehyde (PFA)
for 30 min at room temperature. After brief wash, the cells
were then perforated with 0.5% triton X-100 for 15 min, and
blocked with 4% goat serum for 30 min at room temperature.
The cells were incubated with appropriated diluted primary
antibodies at 4◦ C overnight with gentle agitation. After 3
washes with 1× PBS, the cells were incubated with Alexa Fluor
594/488-conjugated secondary antibodies and 40 ,6-diamidino-2phenylindole (DAPI) for 1 h at room temperature with gentle
agitation. Fluorescent images were acquired using NIS-Elements
Imaging Software on an inverted Nikon Eclipse Ti fluorescence
microscope.

Dual Luciferase Reporter Assay
In a 24-well culture plate, 70% confluent HEK293T cells were
transfected with 50 ng of pRL-TK reporter (herpes simplex virus
thymidine kinase promoter driven renilla luciferase; internal
control), 100 ng of ISRE-luciferase reporter (firefly luciferase;
experimental reporter) plasmid, and 100 ng of each Zika gene
expression plasmid using Lipofectamine 2000. The cells were
incubated at 37◦ C, 5% CO2 for 24 h, and then transfected
with 10 µg/ml of polyI:C which induces cellular RLR signaling
and subsequent IFN-I production. The luciferase activity was
measured 16 h after polyI:C stimulation using a Promega Dual
Glow kit according to the manufacturer’s instructions.

Assay for Type I IFN Bioavailability
To quantify Type I IFNs in the cell culture medium of HEK293T,
a 2fGTH cell line stably expressing an ISRE-luciferase reporter
was used. This cell line responds to type I IFNs and activates
an ISRE-driven luciferase reporter (Wang et al., 2013). Briefly
3 × 105 2fGTH cells/well were seeded and grown in DMEM
supplemented with 10% FBS and antibiotics/antimycotics in a
24-well culture plate at 37◦ C, 5% CO2 overnight. Two hundred
microliters of pre-stimulated HEK293T culture medium was
added to the 2fGTH-ISRE-Luc cells and incubated at 37◦ C, 5%
CO2 for 10 h. A serial twofold dilution of recombinant human
IFN-β served as positive controls and was used for plotting
standard curve. Unstimulated HEK293T cell culture medium
served as a negative control.

Frontiers in Microbiology | www.frontiersin.org

Generation of Gene Knockout With the
CRISPR-Cas9 Technology
The gene specific guide RNA was cloned into lentiCRISPRv2
vector and co-transfected into HEK293T cells with
the packaging plasmids pVSV-G and psPAX2 (Sanjana
et al., 2014; Shalem et al., 2014). Forty-eight hours after
transfection, the lentiviral particles in the cell culture

3

June 2018 | Volume 9 | Article 1350

Ma et al.

Zika Virus Inhibits RLR Signaling

ZIKA virus was 50 CCGCTGCCCAACACAAG-30
50 CCACTAACGTTCTTTTGCAGACAT-30 .

media were applied to trophoblasts for 48 h. The
transduced cells were then selected with puromycin at
1 µg/ml for 48–72 h. Successful knockout clones were
confirmed by immunoblotting. The guide RNA for RIG-I,
MDA5, and MAVS was TCCTGAGCTACATGGCCCCC,
CTTTCTGCCTGCAGAGGTGA, and AAGTTACCCCATGCC
TGTCC, respectively. The wild type control was lentiCRISPRv2
vector only.

and

Graphing and Statistics
For all the bar graphs, data were expressed as mean ± SEM.
A standard two-tailed unpaired Student’s t-test was used for
statistical analysis. The results with a p-value ≤ 0.05 were
considered significant.

Reverse Transcription and Quantitative
PCR (qPCR)

RESULTS

Cells were collected in 350 µl of RLT buffer (QIAGEN
RNeasy mini kit). RNA was extracted following the QIAGEN
manual exactly, reverse-transcribed into cDNA using the
BIO-RAD iScriptTM cDNA Synthesis Kit. qPCR was performed
with gene-specific primers and SYBR Green master mix.
Results were calculated using the −11Ct method and beta
actin gene as an internal control. The qPCR primers and
probes for immune genes were reported in our previous
studies (Wang et al., 2010, 2012). The primer pair for

Identification of ZIKV Genes That
Interfere With the RLR Pathway
The cytosolic RLRs recognize viral dsRNA intermediates and
induces type I IFNs to control viral replication. We first asked
if this signaling pathway was also important for anti-ZIKV
responses in human trophoblast, a cell type of the placental
barrier that is physiologically relevant to ZIKV congenital
transmission (Miner et al., 2016). We first successfully abolished

FIGURE 1 | The RLR signaling is essential for induction of type I IFN responses to and control of ZIKV infection in human trophoblasts. (A) Immunoblots of RIG-I,
MDA5, MAVS and a house keeping gene actin protein expression in wild type (WT) and knockout human trophoblasts. (B) Fluorescent microscopic images of GFP
in trophoblasts infected with VSV-GFP at a multiplicity of infection (MOI) of 0.1 for 20 h. Objective: 5×, scale bar: 50 µM. qPCR quantification of cellular (C) viral RNA
and (D) IFNB1 mRNA in trophoblasts infected with ZIKV FLR at a MOI of 5 for the indicated time. The bars/data points in C,D are the mean + SEM of the results,
n = 3. ∗ p < 0.0.5; ∗∗ p < 0.01 (Student’s t-test). The data shown are representative of three independent experiments.
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FIGURE 2 | NS4A inhibits polyI:C- induced type I IFN responses. (A) Immunoblots of the FLAG-tagged ZIKV protein expression in HEK293T cells. The proteins were
detected by immunoblotting with an anti-FLAG antibody. Actin is a housekeeping protein control. The arrow indicates a non-specific band. The molecular weights in
kDa are marked to the right of the blots. (B) Quantification of ISRE-Luc activity in HEK293T cells transfected with either 100 ng of empty vector or the indicated ZIKV
gene expressing plasmid for 24 h and then stimulated with 10 µg/ml of heavy molecular weight polyI:C-H for 16 h. Data are expressed as fold induction over
unstimulated cells. (C) Quantification of ISRE-Luc activity by a dual luciferase reporter assay similar to B except that an increasing dose of vector and FLAG-NS4A
plasmids was applied. (D) Quantification of ISG15 and IFIT1 mRNA by q-PCR in HEK293T cells transfected with either 100 ng of empty vector or NS4A, and then
stimulated with polyI:C as in B. The bars/data points in B–D represent the mean + SEM of the results, n = 3. ∗ p < 0.0.5; ∗∗ p < 0.01 (Student’s t-test). The data
shown are representative of three independent experiments.

MDA5, RIG-I, and MAVS protein expression using the CRISPRCas9 system (Figure 1A), and validated their phenotype using
vesicular stomatitis virus (VSV) which is predominantly sensed
by RIG-I. Indeed, the viral load was the same in MDA5−/−
as WT, but much higher in RIG-I −/− and MAVS/− than WT
cells (Figure 1B). We next assessed ZIKV infection and type
I IFN expression in these cells. The abundance of intracellular
ZIKV RNA was modestly higher in RIG−/− and MDA5−/−
than wild type (WT) cells at 36 and 72 h after infection, while
it was dramatically increased by ∼20–40 times in MAVS−/−
compared to WT cells (Figure 1C). The IFNB1 mRNA induction
was reduced by ∼7-fold in RIG−/− and MDA5−/− , and almost
completely abolished in MAVS−/− compared to WT cells
(Figure 1D). These results clearly demonstrate an essential role
for the RLR signaling in type I IFN induction and resisting ZIKV
infection in human trophoblasts. Next, we screened 9 individual

Frontiers in Microbiology | www.frontiersin.org

ZIKV proteins to assess whether any would dampen type I IFN
response. We subcloned the genes of ZIKV FS13025 strain into
a pcDNA3.1-FLAG vector and transfected these plasmids into
HEK293T cells, an established cell line for study of functional
RLR signaling. We confirmed each ZIKV protein expression
by Western blotting using an anti-FLAG antibody (Figure 2A).
Then we assessed the impact of each ZIKV protein on type I IFN
response which is rapidly induced by viral infection and critical
for controlling initial viral replication. We used an ISRE-driven
luciferase reporter system to determine type I IFN induction by
polyI:C, a synthetic double-stranded RNA that activates the RLR
signaling. We noted that all the ZIKV proteins reduced ISRELuc to variable degrees compared to the vector control, with the
most dramatic reduction seen with NS4A (Figure 2B). We hereby
focused on NS4A and validated its inhibitory function using 3
different doses of NS4A plasmid DNA. We noted that NS4A
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NS4A Suppresses RIG-I and
MDA5-Induced Type I Interferons
The aforementioned results demonstrate that NS4A interferes
with the RLR pathway and prompt us to pinpoint the exact
step that NS4A targets. We expressed NS4A concurrently with
1RIG-I, MDA5, MAVS, TBK1, or IRF3-5D, the key components
that can induce ISRE-Luc when transiently overexpressed
(Wang et al., 2013). NS4A repressed both RIG-I- and MDA5induced ISRE-Luc activity significantly and had a modest
effect on MAVS-mediated ISRE-Luc induction (Figure 4A).
However, NS4A did not significantly affect TBK1 or IRF3induced ISRE activity (Figure 4A). Given the possibility of
strain-dependent variations in ZIKV immune evasion, we tested
NS4A of a recent South American strain FLR 2015 and noted
a similar result (Figure 4B), suggesting the immune evasion
capacity of NS4A is conserved during ZIKV evolution. In
addition to quantification of intracellular interferon promoter
activity with an ISRE reporter system, we conducted a
bioassay to measure the concentrations of secreted type I
IFN proteins (mainly IFN-β) by HEK293T. NS4A reduced
both RIG-I and MDA5-induced IFN-β protein expression
significantly compared to vector control (Figure 4C). Ectopic
expression of a protein may squelch concurrent expression of
another protein non-specifically. In our experimental conditions,
NS4A did not impair 1RIG-I, MDA, or MAVS expression
(Figure 4D). These results suggest that NS4A targets the
upstream of the RLR pathway, e.g., RIG-I and MDA5
directly.

FIGURE 3 | NS4A does not interfere with TLR3 or TLR4 signaling.
(A) Quantification of ISRE-Luc activity in HEK293T cells transfected with Myc
vector + FLAG-TLR3 or Myc-NS4A + FLAG-TLR3 (100 ng each) for 16 h and
then stimulated with 20 µg/ml low molecular weight polyI:C-L (no transfection)
for 24 h. (B) Quantification of IFNB1 and TNFA mRNA by qPCR. The cells
were treated similarly as in A except that polyI:C stimulation was 8 h.
(C) Quantification of ISRE-Luc activity in stable TLR4/MD2/CD14-expressing
HEK293 cells transfected with 100 ng of Myc vector or Myc-NS4A plasmid for
12 h and stimulated with 100 ng/ml of LPS for 24 h. (D) Quantification of
IFNB1 and TNFA mRNA by qPCR. The cells were treated similarly as in
C except that LPS stimulation was 8 h. The results are expressed as fold
change over unstimulated cells. The bars represent the mean + SEM of the
results, n = 3. Three biological replicates were pooled for qPCR. ∗ p < 0.0.5;
∗∗ p < 0.01 (Student’s t-test). The data shown are representative of three
independent experiments.

NS4A Interacts With MAVS
The aforementioned results suggest that NS4A interferes with
RLR function directly; we then asked if it is a dominant
negative interactor of RLRs. We co-expressed Myc-NS4A
together with FLAG tagged RIG-I, MDA5, MAVS, or 1RIG-I
(only the two CARDs domain mediating binding to MAVS)
respectively, and then performed a co-immunoprecipitation
assay using an anti-FLAG antibody. We observed that only
FLAG-MAVS, but surprisingly not RIG-I, MDA5, or 1RIG-I,
co-immunoprecipitated with Myc-NS4A (Figure 5A). It has
been well established that the N-terminal CARD domain of
MDA5/RIG-I interacts with the N-terminal CARD of MAVS to
activate recruitment of downstream TRAF3/6 to its C-terminus.
We asked if NS4A competes with MDA5/RIG-I for binding to
the CARD of MAVS. Indeed, NS4A co-precipitated with the
CARD-containing truncate of MAVS, most strongly with the
CARD only (1–100) (Figure 5B). Furthermore, NS4A expression
reduced the amount of endogenous MAVS bound by FLAGMDA5 (Figure 5C) and FLAG-1RIG-I in a dose-dependent
manner (Figure 5D). By immunofluorescent microscopy, we
observed that endogenous MAVS colocalized with MDA5 very
well in polyI:C-stimulated cells (polyI:C+Vec) when compared
to unstimulated cells (Mock). The co-localizations between
MAVS and MDA5, however, were significantly reduced in the
presence of NS4A (polyI:C+NS4A) (Figure 5E). These results
indicate that NS4A occupies the CARD of MAVS to block
MDA5/RIG-I access.

repressed polyI:C-induced ISRE-Luc activity in a dose-dependent
manner (Figure 2C). Consistently, the mRNA expression of
representative interferon stimulated genes (ISG) ISG15 and IFIT1
was also repressed significantly by NS4A (Figure 2D). These
data suggest that NS4A interferes with the RLR signaling. We
next tested if NS4A influenced other virus-sensing pathways
such as the Toll-like receptors (TLRs). Because HEK293T cell
line expresses little TLR3, a modified TLR3 that localizes to the
plasma membrane (Wang et al., 2013) together with the empty
vector or NS4A was transiently expressed and its signaling was
stimulated with non-transfected polyI:C (to avoid stimulation
of intracellular RLRs). As shown in Figure 3A, the ISRE-Luc
induction was not affected by NS4A compared to the vector
control. Consistently, the IFNB1 and TNFA mRNA expression
was the same between the vector and NS4A (Figure 3B). We
observed a similar result with the TLR4 signaling pathway
(Figures 3C,D). These results indicate that NS4A does not
interfere with TLR signaling.
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FIGURE 4 | NS4A interferes with RIG-I and MDA5-induced type I interferons. Quantification of ISRE-Luc activity in HEK293T cells transfected with 100 ng of FLAG
vector or FLAG-NS4A of A ZIKV FS13025 and B FLR strain, together with the indicated individual immune genes of the RLR pathway for 24 h. The immunoblots
under the bar graph show the FLAG-NS4A and actin protein expression. (C) Quantification of type I IFN bioavailability in the culture media of A. (D) Immunoblots of
FLAG-1RIG-I, MDA5, and MAVS proteins in HEK293T cells treated exactly as in A. The FLAG-tagged protein was detected with an anti-FLAG antibody. The bars in
A–C represent the mean + SEM of the results, n = 3. ∗ p < 0.0.5; ∗∗ p < 0.01 (Student’s t-test). The data shown are representative of three independent experiments.

(Fredericksen et al., 2008; Suthar et al., 2010). Our results
suggest that MDA5 and RIG-I each contribute to a significant
amount of anti-ZIKV type I IFN responses. RIG-I may rapidly
initiate early; while MDA5 maintains late innate immune
responses to WNV (Errett et al., 2013). This sequential, nonredundant function of RIG-I and MDA5 ensures an effective
immune response throughout the course of viral infection.
Understanding the major antiviral pathways in trophoblasts
is physiologically meaningful as these cells form a barrier
to ZIKV congenital transmission and prevent pathogenesis
of microcephaly. Given its essential role in induction of
anti-ZIKV immune responses in trophoblasts, stimulation of
the RLR signaling may thus be potentially prophylactic and
therapeutic against ZIKV complications. Indeed, as proof-ofprinciple, RIG-I agonists have been recently shown to potently
restrict ZIKV infection in human dendritic cells (Bowen et al.,
2017).
It has been established that flaviviruses have evolved
complex mechanisms to avoid the host immune responses
including the RLR signaling [reviewed by Asif et al. (2017)

DISCUSSION
The relative contribution of different classes of pathogen
pattern recognition receptors (PRRs) to innate antiviral immune
responses may vary with viral species and tissue cell types.
A previous study revealed that the cytoplasmic PRR, MDA5,
and RIG-I, recognized a specific subset of RNA viruses (Kato
et al., 2006). However, both MDA5 and RIG-I play a nonredundant additive role in type I IFN induction by flaviviruses
(Wilkins and Gale, 2010). A recent study demonstrated that
TLR3, MDA5, and RIG-I all play a moderate role in limiting
ZIKV infection in primary human skin fibroblasts (Hamel
et al., 2015). Our results, however, reveal that the RLR
pathway is essential for inducing type I IFN responses to
ZIKV infection in human trophoblasts. Knockout of either
RIG-I or MDA5 reduced, while deletion of the common
adaptor for both RIG-I and MDA5, MAVS, almost completely
abolished type I IFN induction and supports productive
ZIKV infection. Similar results have been previously reported
for a sibling of ZIKV, West Nile virus (WNV) studies
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FIGURE 5 | NS4A interacts with MAVS and blocks RLR binding to MAVS. (A) Co-immunoprecipitation (co-IP) of MAVS with NS4A from HEK293T cells transfected
with Myc-NS4A and the indicated FLAG-tagged genes using an anti-FLAG monoclonal antibody, followed by immunoblotting (IB). WCE, whole-cell extract. (B) co-IP
of the truncated forms of MAVS with NS4A from HEK293T cells transfected with Myc-NS4A and FLAG-tagged MAVS mutants using an anti-FLAG monoclonal
antibody. co-IP of (C) FLAG-MDA5 or (D) FLAG-1RIG-I with endogenous MAVS from HEK293T cells transfected with FLAG-MDA5 or FLAG-1RIG-I and Myc vector
or increasing amounts of Myc-NS4A. The plasmid DNA molar ratio of Myc- NS4A to FLAG-MDA5 is 1:3; to FLAG-1RIG-I are 1:6, 1:3, and 1:2.
(E) Immunofluorescent staining of endogenous MAVS and MDA5 in human trophoblasts. Trophoblasts were untreated (Mock) or transfected with either a FLAG
vector or FLAG-NS4A for 24 h and then stimulated with 20 µg/ml of heavy molecular weight polyI:C-H for 8 h. MDA5/MAVS was stained with a rabbit anti-MDA5
and mouse anti-MAVS antibody followed by secondary antibodies conjugated with Alexa Fluor 594/488. The nuclei were counter-stained with DAPI. The images
were acquired using an inverted Nikon Eclipse Ti fluorescence microscope. The arrows indicate colocalizations of MDA5 and MAVS. In (A–C) actin is a
housekeeping protein control. The arrow heads point to non-specific bands. The data shown are representative of three independent experiments.

action is similar to that of dengue virus NS4A which disrupts
RLR-MAVS interaction and also MAVS signaling (He et al.,
2016). Since both RIG-I and MDA5 contribute to the type
I IFN responses to ZIKV infection, blocking MAVS is more
energy-efficient than inhibiting individual RIG-I and MDA5
separately.
The ISRE luciferase reporter system reflects both primary and
secondary type I IFN response, as ISRE can be activated by
both IRF3/7 and STAT1/2. However, NS4A specifically inhibits
RLRs-, but not their downstream factors like MAVS/TBK1/IRF3induced ISRE reporter activity. These results suggest that NS4A
does not target the JAK-STAT pathway.
In addition to a role for ZIKV NS4A in antagonizing RLR
signaling, NS4A has been recently discovered to interact with
NS4B and induce cellular autophagy in human neural stem
cells by interfering with the Akt-mTOR signaling, leading to
defective neurogenesis characteristic of microcephaly (Liang
et al., 2016). Induction of autophagy by NS4A/4B may also
amplify ZIKV replication (Cao et al., 2017). Thus, NS4A may
be potentially involved in both immune evasion and abnormal
brain development, two key aspects of ZIKV pathogenesis.
The multidimensional pathogenic features of NS4A make it a
potential therapeutic target.

and Chen et al. (2017)]. As a new re-emerging flavivirus, ZIKV
has recently attracted much public attention for its potential
association with neonatal microcephaly and adult GuillainBarre Syndrome (Asif et al., 2017). Its pathogenesis, however,
remains largely obscure. ZIKV NS5 was recently shown to
induce human STAT2 degradation (Grant et al., 2016); NS4A
and NS4B inhibit neurogenesis via Akt-mTOR signaling and
induce autophagy (Liang et al., 2016). In this study, we
observed that almost all the ZIKV protein overexpression downregulated polyI:C- induced type I IFN response, with NS4A
being the most potent. We further found that NS4A repressed
the RLR signaling by targeting MAVS. Our conclusions are
supported by several lines of evidence. First, NS4A dramatically
repressed type I IFN induction by ectopic overexpression of
MDA5 and RIG-I, but not MAVS, TBK1, or IRF3. Second,
NS4A interacted with the N-terminal CARD of MAVS but
not RIG-I or MDA5, and competed with MDA5/RIG-I for
binding to MAVS. However, binding of NS4A to MAVS
did not impair IFN-I induction by MAVS overexpression.
These results seem contradictory. But the mechanisms of
MAVS activation are different under overexpression or viral
infection/polyI:C stimulation conditions. When overexpressed,
MAVS undergoes self-oligomerization and recruits downstream
TRAF3/6 to its C-terminus independently of upstream RIGI/MDA5. Thus NS4A binding to the N-terminal CARD of
MAVS does not influence its downstream signaling events. In
the ZIKV infection/polyI:C stimulation conditions, MAVS needs
to be activated by RIG-I/MDA5 binding to its CARD domain,
which can be blocked by NS4A. The mode of ZIKV NS4A
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